Literature DB >> 33717772

Cefepime-Induced Encephalopathy With Seizures in a Pediatric Patient With End-Stage Renal Disease Rapidly Reversed by High-Efficiency Hemodialysis.

Siddharth Shah1, Stephanie Bland2.   

Abstract

Cefepime-induced encephalopathy with associated complications is a relatively rare but known adverse reaction that appears to occur more commonly in the elderly population with concomitant renal dysfunction or pre-existing central nervous system disease. The description of neurological features in pediatric patients secondary to cefepime-induced encephalopathy has rarely been reported, often delaying diagnosis and treatment. We report a 13-year-old female with end-stage renal disease, maintained on hemodialysis, who developed acute neurological symptoms of aphasia, myoclonus, hallucinations, seizures, and altered mental status after two days of cefepime treatment. After prompt discontinuation of cefepime and urgent hemodialysis, the neurological symptoms were resolved. Our patient had complete neurological recovery within 24 hours of the initial presentation of neurological symptoms. Recognizing the possibility of encephalopathy related to cefepime administration in high-risk pediatric patients should prompt close neurological monitoring when under treatment. Hemodialysis may help rapidly reverse the symptoms of cefepime-induced encephalopathy.
Copyright © 2021, Shah et al.

Entities:  

Keywords:  cefepime; encephalopathy; hemodialysis; high-efficiency

Year:  2021        PMID: 33717772      PMCID: PMC7954516          DOI: 10.7759/cureus.13842

Source DB:  PubMed          Journal:  Cureus        ISSN: 2168-8184


  13 in total

Review 1.  Efficacy and safety of cefepime in pediatric patients: a systematic review and meta-analysis.

Authors:  Elisabeth E Adderson; Patricia M Flynn; James M Hoffman
Journal:  J Pediatr       Date:  2010-09       Impact factor: 4.406

2.  Myoclonic status epilepticus induced by cefepime overdose requiring haemodialysis.

Authors:  Aude Garin; Florent Bavozet
Journal:  BMJ Case Rep       Date:  2019-06-06

Review 3.  Review of the pharmacokinetics of cefepime in children.

Authors:  J L Blumer; M D Reed; C Knupp
Journal:  Pediatr Infect Dis J       Date:  2001-03       Impact factor: 2.129

4.  Cefepime-induced encephalopathy in end-stage renal disease patients.

Authors:  Ryo Nakagawa; Kenichiro Sato; Yoshikazu Uesaka; Takashi Mitsuki; Kanya Kondo; Atsushi Wake; Yoshifumi Ubara; Mami Kanzaki
Journal:  J Neurol Sci       Date:  2017-03-16       Impact factor: 3.181

Review 5.  Intermittent hemodialysis treatment in cefepime-induced neurotoxicity: case report, pharmacokinetic modeling, and review of the literature.

Authors:  Laila-Yasmin Mani; Sébastien Kissling; Dragana Viceic; Bruno Vogt; Michel Burnier; Thierry Buclin; Delphine Renard
Journal:  Hemodial Int       Date:  2014-07-23       Impact factor: 1.812

6.  Pharmacokinetics and pharmacodynamics of cefepime in patients with various degrees of renal function.

Authors:  Vincent H Tam; Peggy S McKinnon; Ronda L Akins; George L Drusano; Michael J Rybak
Journal:  Antimicrob Agents Chemother       Date:  2003-06       Impact factor: 5.191

Review 7.  Cefepime-Induced Neurotoxicity Despite Dose Adjustment for Renal Disease: A Brief Report and Review of the Literature.

Authors:  Holly Lindsay; Stephanie Gruner; Julienne Brackett
Journal:  J Pediatric Infect Dis Soc       Date:  2017-06-01       Impact factor: 3.164

8.  Cefepime-induced non-convulsive status epilepticus in a peritoneal dialysis patient.

Authors:  Harika Alpay; Ozge Altun; Nese Karaaslan Biyikli
Journal:  Pediatr Nephrol       Date:  2004-02-21       Impact factor: 3.714

9.  Cefepime is Associated with Acute Encephalopathy in Critically Ill Patients: A Retrospective Case-Control Study.

Authors:  Tarun D Singh; John C O'Horo; Courtney N Day; Jay Mandrekar; Alejandro A Rabinstein
Journal:  Neurocrit Care       Date:  2020-12       Impact factor: 3.210

10.  Three-times-weekly, post-dialysis cefepime therapy in patients on maintenance hemodialysis: a retrospective study.

Authors:  Eric Descombes; Filipe Martins; Ould Maouloud Hemett; Veronique Erard; Christian Chuard
Journal:  BMC Pharmacol Toxicol       Date:  2016-02-04       Impact factor: 2.483

View more
  1 in total

1.  Cefepime-Induced Nonconvulsive Status Epilepticus in a Pediatric Patient with Normal Renal Function.

Authors:  Clever Nguyen; Taylor Clegg; Ashutosh Kumar; Sita Paudel
Journal:  Child Neurol Open       Date:  2022-08-07
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.